PRESUMED OCULAR HISTOPLASMOSIS

Clinical trials for PRESUMED OCULAR HISTOPLASMOSIS explained in plain language.

Never miss a new study

Get alerted when new PRESUMED OCULAR HISTOPLASMOSIS trials appear

Sign up with your email to follow new studies for PRESUMED OCULAR HISTOPLASMOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Eye injection shows promise for rare Fungal-Related blindness

Disease control Recruiting now

This study tests whether faricimab (Vabysmo), an FDA-approved eye injection for other retinal diseases, can safely treat abnormal blood vessel growth in the eye caused by presumed ocular histoplasmosis syndrome. About 25 adults with this condition will receive an initial injectio…

Matched conditions: PRESUMED OCULAR HISTOPLASMOSIS

Phase: PHASE4 • Sponsor: Cincinnati Eye Institute, Southwest Ohio • Aim: Disease control

Last updated Jul 12, 2026 00:00 UTC

PRESUMED OCULAR HISTOPLASMOSIS

Get alerted when new PRESUMED OCULAR HISTOPLASMOSIS trials appear

Eye injection shows promise for rare Fungal-Related blindness